Tag: Prescription Drugs
In-Hospital Adverse Events Similar for Haloperidol, Atypical Antipsychotics
Comparable rates of in-hospital adverse events seen among seniors prescribed oral antipsychotics after major surgery
Availability of CVD Meds Varies by Low-Cost Generic Program
Variation in coverage seen by program, drug, and cardiovascular disease condition
Apixaban Has Lower Bleeding Risk for Initial Anticoagulation for Venous Thromboembolism
During extended treatment, bleeding risk was similar for apixaban and rivaroxaban
Most of the Effect of Paroxetine for Treating Hot Flashes May Be Placebo Effect
Authors say mean treatment effect for hot flash frequency may only be 21 percent
Concizumab May Be Effective Prophylaxis for Hemophilia A or B With Inhibitors
Overall median annualized bleeding rate was 0 with concizumab
Rates of Tx Retention for Rifaximin Low Despite Benefits for Hepatic Encephalopathy
Lower treatment retention rates seen with 30-day, out-of-pocket costs ≥$150
Heart, Diabetes, Cancer Drugs on List for Medicare Price Negotiations, White House Says
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations
Most Immunosuppressive Drugs Not Linked to Risk for Cancer
No associations seen for TNF inhibitor, antimetabolite, calcineurin inhibitor, or alkylating agent classes with cancer
USPSTF Reaffirms Recommendation of PrEP for Those at Increased HIV Risk
Considerable net benefit seen for use of effective antiretroviral therapy for reducing risk for HIV acquisition
Tardive Dyskinesia Has Considerable Impact on Multiple Domains
Considerable impact scores reported in physical, psychological, social domains; professional lives also affected
